Literature DB >> 22378289

Reply to Ross' commentary: Reproductive benefit through newborn screening: preferences, policy and ethics.

Yvonne Bombard, Fiona A Miller.   

Abstract

Mesh：

Year:  2012        PMID： 22378289      PMCID： PMC3330232          DOI： 10.1038/ejhg.2012.25

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  17 in total

1.  Newborn screening technology: proceed with caution.

Authors:  Jeffrey R Botkin; Ellen Wright Clayton; Norman C Fost; Wylie Burke; Thomas H Murray; Mary Ann Baily; Benjamin Wilfond; Alfred Berg; Lainie Friedman Ross
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

2.  Changing perspectives on the benefits of newborn screening.

Authors:  Donald B Bailey; Laura M Beskow; Arlene M Davis; Debra Skinner
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

3.  A vision of the future of newborn screening.

Authors:  Duane Alexander; Peter C van Dyck
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

4.  Clinical and ethical considerations in managing carrier detection.

Authors:  Lainie Friedman Ross; Ellen Wright Clayton
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

5.  Newborn screening for developmental disabilities: reframing presumptive benefit.

Authors:  Donald B Bailey; Debra Skinner; Steven F Warren
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

Review 6.  Uptake rates for breast cancer genetic testing: a systematic review.

Authors:  Mary E Ropka; Jennifer Wenzel; Elayne K Phillips; Mir Siadaty; John T Philbrick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

7.  Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Authors:  D J Ciske; A Haavisto; A Laxova; L Z Rock; P M Farrell
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

8.  Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.

Authors:  S Creighton; E W Almqvist; D MacGregor; B Fernandez; H Hogg; J Beis; J P Welch; C Riddell; R Lokkesmoe; M Khalifa; J MacKenzie; A Sajoo; S Farrell; F Robert; A Shugar; A Summers; W Meschino; D Allingham-Hawkins; T Chiu; A Hunter; J Allanson; H Hare; J Schween; L Collins; S Sanders; C Greenberg; S Cardwell; E Lemire; P MacLeod; M R Hayden
Journal:  Clin Genet       Date:  2003-06       Impact factor: 4.438

9.  Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Authors:  E H Mischler; B S Wilfond; N Fost; A Laxova; C Reiser; C M Sauer; L M Makholm; G Shen; L Feenan; C McCarthy; P M Farrell
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124

10.  Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.

Authors:  P G Wheeler; R Smith; H Dorkin; R B Parad; A M Comeau; D W Bianchi
Journal:  Genet Med       Date:  2001 Nov-Dec       Impact factor: 8.822
View more
  3 in total

Review 1.  Fostering caring relationships: Suggestions to rethink liberal perspectives on the ethics of newborn screening.

Authors:  Simone van der Burg; Anke Oerlemans
Journal:  Bioethics       Date:  2018-03       Impact factor: 1.898

Review 2.  Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.

Authors:  Tessel Rigter; Lidewij Henneman; Ulf Kristoffersson; Alison Hall; Helger G Yntema; Pascal Borry; Holger Tönnies; Quinten Waisfisz; Mariet W Elting; Wybo J Dondorp; Martina C Cornel
Journal:  Hum Mutat       Date:  2013-07-16       Impact factor: 4.878

3.  SPATIAL DISTRIBUTION OF NEWBORNS WITH SICKLE CELL TRAIT IN SERGIPE, BRAZIL.

Authors:  Débora Cristina Fontes Leite; Rosana Cipolotti; Ricardo Queiroz Gurgel; Paulo Ricardo Saquete Martins Filho; Gabriel Dantas Lopes
Journal:  Rev Paul Pediatr       Date:  2020-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.